2018/0134/EE
EC/EFTA
EE Estonie
  • C00C - PRODUITS CHIMIQUES
2018-07-04
2018-04-09
Narcotic drugs

Amendment of Regulation No 73 of the Minister for Social Affairs of 18 May 2005 on conditions and procedures for handling narcotic drugs and psychotropic substances for medical and research purposes, and conditions and procedures for keeping records and reporting in that area and schedules of narcotic drugs and psychotropic substances

Schedules I and III of narcotic drugs and psychotropic substances listed in Annex 1 to Regulation No 73 by the Minister for Social Affairs of 18 May 2005 is amended as follows:

1) Schedule I of narcotic drugs and psychotropic substances is aligned with the UN Convention on Psychotropic Substances of 1971 by replacing ‘Tetrahydrocannabinol (THC), isomers and their stereochemical variants’ with ‘The following tetrahydrocannabinol (THC) isomers and their stereochemical variants:

• 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;

• (9R,10aR)-8,9,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;

• (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;

• (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;

• 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;

• (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol’.

2) In Schedule III of narcotic drugs and psychotropic substances, ‘Dronabinol’ is replaced by ‘Delta-9-tetrahydrocannabinol and its stereochemical variants (including dronabinol, (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol)’. The basis for the amendment is the evaluation made in the 44th Report of WHO Expert Committee on Drug Dependence.